BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Clinical Outcome
4 results:

  • 1. Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
    Shindo Y; Hazama S; Suzuki N; Iguchi H; Uesugi K; Tanaka H; Aruga A; Hatori T; Ishizaki H; Umeda Y; Fujiwara T; Ikemoto T; Shimada M; Yoshimatsu K; Takenouchi H; Matsui H; Kanekiyo S; Iida M; Koki Y; Arima H; Furukawa H; Ueno T; Yoshino S; Fujita T; Kawakami Y; Nakamura Y; Oka M; Nagano H
    J Exp Clin Cancer Res; 2017 Feb; 36(1):36. PubMed ID: 28241889
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
    Ohmoto A; Rokutan H; Yachida S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome.
    Venturini M; Sallemi C; Colantoni C; Agostini G; Balzano G; Esposito A; Secchi A; De Cobelli F; Falconi M; Piemonti L; Maffi P; Del Maschio A
    Br J Radiol; 2016 Aug; 89(1064):20160246. PubMed ID: 27327404
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.